PharmX Technologies Ltd (ASX: PHX) Share Price and News

Ms Shaw on arrival in Australia became Director of Nursing and Chief Executive Officer of two private hospitals. She has founded and lead several healthcare companies which have either been sold or listed on the ASX and has worked on many international mergers and acquisitions with private equity companies in the UK, Australia and the USA. Currently she coowns Sydney Breast Clinic and holds existing board positions at Magentus, Ellerston JAADE Australian Private Assets Fund, Mable Technologies, Pharmx and Prospection. She also serves as a Non Executive Director at Pinnacle Charitable Foundation. She is chair of the Risk Committee.

Mr Newbery has over 35 years of experience in senior executive and Board roles for ASX listed companies operating in the technology, telecommunications, urban services and facilities management sectors. He is also Chairman of Repurpose It, a Victorian based business focused on the recycling of construction and demolition materials and organics , Chairman of Energy Locals, a national provider focussed on the provision of embedded networks to multi dwelling buildings, Chairman of Total Ventilation Hygiene, a leading HVAC service provider with operations throughout Australia and a Non executive director of Xref Limited, a listed provider of human resources technology solutions. Previously he held roles as Head of Corporate Finance at Downer EDI Limited, Australias leading urban services and facilities management provider, the Chief Executive Officer of ASX listed Clarity OSS Limited which developed operational support systems for telecommunication operators across the globe and as Chairman of UK based banknote trading system developer IMX Software.

Mr England has over 35 years of experience and high level global relationships formed through his consulting and senior management roles in Australia, the UK and Europe. He held senior management roles with the global health and beauty company Alliance UniChem, which operates 13,000 pharmacies and distributes across 11 countries. As Group Director for Alliance UniChem, he was responsible for merger, acquisition and service agreement opportunities with key global network partners. Previously, he was also CEO of Alliance UniChem Retail International with responsibility for 300 pharmacies across Europe. He is currently a Principal of Sydney based international retail pharmacy consultancy IQ Consulting. He is member of the Risk Committee.

Mr Mellis has seen his career develop and manage consumer health brands, and consumer goods businesses in Australia, NZ, UK, USA and Europe. His 25 years and more experience in the industry has provided him with experience in managing large multi disciplinary teams, with multi billion dollar portfolios, across a wide variety of market channels. More recently, he has held the dual role of Chief Commercial Officer of DBG Health, and Chief Executive Officer of Vidacorp, the Consumer Health & Beauty division of DBG Health.

-

-

-

-

-